phenylephrine hydrochloride 2 MG/ML / triprolidine hydrochloride 0.5 MG/ML Oral Solution
- RxCUI
- 1094434
- RxNorm name
- phenylephrine hydrochloride 2 MG/ML / triprolidine hydrochloride 0.5 MG/ML Oral Solution
- Display name
- Phenylephrine/Triprolidine (Oral Liquid)
- Full name
- phenylephrine hydrochloride 2 MG/ML / triprolidine hydrochloride 0.5 MG/ML Oral Solution
- Term type
- SCD
- Status
- Active
- Strength
- 10-2.5 mg/5ml
- Dose form
- Sol
- Route
- Oral Liquid
- Updated
- 2026-07-27 06:53:47
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 042011
- Active start
- 042011
- Multiple ingredient
- YES
- Branded
- NO
Ingredients And Strength#
Derived Ingredient Concepts#
RxNav Current And Historical NDCs#
NDC11, Source, Active table| NDC11 | Source | Active |
|---|
| 28595080316 | rxnav_ndcs | yes |
| 70868070316 | rxnav_ndcs | yes |
Drug Classes#
Source, Class ID, Class table| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|
| ATC | C01CA | Adrenergic and dopaminergic agents | ATC1-4 | | phenylephrine |
| ATC | C05AX | Other agents for treatment of hemorrhoids and anal fissures for topical use | ATC1-4 | | phenylephrine |
| ATC | R06AX | Other antihistamines for systemic use | ATC1-4 | | triprolidine |
| ATC | R01BA | Sympathomimetics | ATC1-4 | | phenylephrine |
| ATC | S01FB | Sympathomimetics excl. antiglaucoma preparations | ATC1-4 | | phenylephrine |
| ATC | S01GA | Sympathomimetics used as decongestants | ATC1-4 | | phenylephrine |
| ATC | R01AB | Sympathomimetics, combinations excl. corticosteroids | ATC1-4 | | phenylephrine |
| ATC | R01AA | Sympathomimetics, plain | ATC1-4 | | phenylephrine |
| FDASPL | N0000186105 | alpha-1 Adrenergic Agonist | EPC | has_epc | phenylephrine |
| MEDRT | D010656 | Phenylephrine | CHEM | has_ingredient | phenylephrine |
| MEDRT | D010656 | Phenylephrine | CHEM | has_ingredient | phenylephrine hydrochloride |
| MEDRT | D013447 | Sulfites | CHEM | ci_chemclass | phenylephrine hydrochloride |
| MEDRT | D013447 | Sulfites | CHEM | ci_chemclass | phenylephrine |
| MEDRT | D014311 | Triprolidine | CHEM | has_ingredient | triprolidine |
| MEDRT | D014311 | Triprolidine | CHEM | has_ingredient | triprolidine hydrochloride |
| MEDRT | D003233 | Conjunctivitis, Allergic | DISEASE | may_treat | triprolidine hydrochloride |
| MEDRT | D003233 | Conjunctivitis, Allergic | DISEASE | may_treat | triprolidine |
| MEDRT | D003327 | Coronary Disease | DISEASE | ci_with | triprolidine hydrochloride |
| MEDRT | D003327 | Coronary Disease | DISEASE | ci_with | triprolidine |
| MEDRT | D003876 | Dermatitis, Atopic | DISEASE | may_treat | triprolidine hydrochloride |
| MEDRT | D003876 | Dermatitis, Atopic | DISEASE | may_treat | triprolidine |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | phenylephrine hydrochloride |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | phenylephrine |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | triprolidine |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | triprolidine hydrochloride |
| MEDRT | D005401 | Fissure in Ano | DISEASE | may_treat | phenylephrine hydrochloride |
| MEDRT | D005401 | Fissure in Ano | DISEASE | may_treat | phenylephrine |
| MEDRT | D005902 | Glaucoma, Open-Angle | DISEASE | may_treat | phenylephrine |
| MEDRT | D005902 | Glaucoma, Open-Angle | DISEASE | may_treat | phenylephrine hydrochloride |
| MEDRT | D006484 | Hemorrhoids | DISEASE | may_treat | phenylephrine |
| MEDRT | D006484 | Hemorrhoids | DISEASE | may_treat | phenylephrine hydrochloride |
| MEDRT | D006973 | Hypertension | DISEASE | ci_with | phenylephrine |
| MEDRT | D006973 | Hypertension | DISEASE | ci_with | phenylephrine hydrochloride |
| MEDRT | D007022 | Hypotension | DISEASE | may_treat | phenylephrine |
| MEDRT | D007022 | Hypotension | DISEASE | may_treat | phenylephrine hydrochloride |
| MEDRT | D015878 | Mydriasis | DISEASE | induces | phenylephrine |
| MEDRT | D015878 | Mydriasis | DISEASE | induces | phenylephrine hydrochloride |
| MEDRT | D011538 | Pruritus Ani | DISEASE | may_treat | phenylephrine hydrochloride |
| MEDRT | D011538 | Pruritus Ani | DISEASE | may_treat | phenylephrine |
| MEDRT | D012220 | Rhinitis | DISEASE | may_treat | triprolidine hydrochloride |
| MEDRT | D012220 | Rhinitis | DISEASE | may_treat | triprolidine |
| MEDRT | D012223 | Rhinitis, Vasomotor | DISEASE | may_treat | phenylephrine hydrochloride |
| MEDRT | D012223 | Rhinitis, Vasomotor | DISEASE | may_treat | phenylephrine |
| MEDRT | D012772 | Shock, Septic | DISEASE | may_treat | phenylephrine hydrochloride |
| MEDRT | D012772 | Shock, Septic | DISEASE | may_treat | phenylephrine |
| MEDRT | D013617 | Tachycardia, Supraventricular | DISEASE | may_treat | phenylephrine |
| MEDRT | D013617 | Tachycardia, Supraventricular | DISEASE | may_treat | phenylephrine hydrochloride |
| MEDRT | D017180 | Tachycardia, Ventricular | DISEASE | ci_with | phenylephrine |
| MEDRT | D017180 | Tachycardia, Ventricular | DISEASE | ci_with | phenylephrine hydrochloride |
| MEDRT | N0000000209 | Adrenergic alpha-Agonists | MOA | has_moa | phenylephrine |
| MEDRT | N0000000209 | Adrenergic alpha-Agonists | MOA | has_moa | phenylephrine hydrochloride |
| MEDRT | N0000000190 | Histamine H1 Receptor Antagonists | MOA | has_moa | triprolidine hydrochloride |
| MEDRT | N0000000190 | Histamine H1 Receptor Antagonists | MOA | has_moa | triprolidine |
| MEDRT | N0000000184 | Monoamine Oxidase Inhibitors | MOA | ci_moa | triprolidine hydrochloride |
| MEDRT | N0000000184 | Monoamine Oxidase Inhibitors | MOA | ci_moa | triprolidine |
| MEDRT | N0000008371 | Conjunctival Arterial Vasoconstriction | PE | has_pe | phenylephrine |
| MEDRT | N0000008371 | Conjunctival Arterial Vasoconstriction | PE | has_pe | phenylephrine hydrochloride |
| MEDRT | N0000008657 | Decreased Histamine Activity | PE | has_pe | triprolidine hydrochloride |
| MEDRT | N0000008657 | Decreased Histamine Activity | PE | has_pe | triprolidine |
| MEDRT | N0000008896 | Decreased Nasal and Sinus Secretions | PE | has_pe | phenylephrine |
| MEDRT | N0000008896 | Decreased Nasal and Sinus Secretions | PE | has_pe | phenylephrine hydrochloride |
Properties#
Category, Property, Value table| Category | Property | Value |
|---|
| ATTRIBUTES | AVAILABLE_STRENGTH | 2 MG/ML / 0.5 MG/ML |
| ATTRIBUTES | GENERAL_CARDINALITY | MULTI |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | PRESCRIBABLE | Y |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| ATTRIBUTES | SCHEDULE | 0 |
| ATTRIBUTES | TTY | SCD |
| CODES | MMSL_CODE | BD26828 |
| CODES | MMSL_CODE | CD26828 |
| CODES | RxCUI | 1094434 |
| CODES | VUID | 4033261 |
| NAMES | Prescribable Synonym | phenylephrine HCl 10 MG / triprolidine HCl 2.5 MG in 5 mL Oral Solution |
| NAMES | RXNAV_STR | phenylephrine hydrochloride 2 MG/ML / triprolidine hydrochloride 0.5 MG/ML Oral Solution |
| NAMES | RxNorm Name | phenylephrine hydrochloride 2 MG/ML / triprolidine hydrochloride 0.5 MG/ML Oral Solution |
| NAMES | RxNorm Synonym | phenylephrine hydrochloride 10 MG / triprolidine hydrochloride 2.5 MG per 5 ML Oral Solution |
| SOURCES | Source | Gold Standard Alchemy |
| SOURCES | Source | National Drug Data File Plus Source Vocabulary |
| SOURCES | Source | Veterans Health Administration National Drug File |